Login to Your Account



New Shores for Antibodies?

Genentech Monoclonal Antibody Activates FGFR, Fights Diabetes

By Anette Breindl
Science Editor

Thursday, December 29, 2011
Ask most folks in biotech about their notion of a typical antibody, and it will probably be an antibody that blocks a receptor to fight cancer, or maybe autoimmune disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription